Cynosure is cashing in on surgery-free cosmetic treatments. Read More
Archive
Filter
Here’s a new bond fund, and a review of how our existing funds will fare when the Fed finally acts. Read More
Optimism about the markets is in short supply as Election Day nears. Read More
Assuming Johnson & Johnson (NYSE: JNJ) stock doesn’t jump more than 10% in value later today, the covered call option we recommended on it last month at a strike price of $125 will expire worthless at the close of business this afternoon since JNJ is currently trading near $114.Of course, the fact… Read More
Over the past three months shares of Best Buy (BBY) gained 25% while the S&P 500 Index declined by nearly 2%. The biggest part of that jump occurred on Aug. 23, the day after Best Buy announced better-than-expected quarterly earnings. And over the past three days it has tacked on… Read More
As the Chief Investment Strategist for Personal Finance, I am often asked by our readers what stocks are the best to own when the market doesn’t know where’s going. And with the S&P 500 going almost nowhere since July, that’s a question I hear quite a bit.However, not all… Read More
A community’s finances and physical condition can tell you a lot about future costs. Read More
Preferred stocks are much safer than common shares, and check out their yields. Read More
Some tech firms have the scale and stability to be considered income investments. Read More
Thanks to the growing demand and short supply of properties, office REITs are taking off. Read More